| Dr Thomas Le, PHARMD | |
|
150 E Yorba Linda Blvd, Placentia, CA 92870-3327 | |
| (714) 528-3112 | |
| Not Available |
| Full Name | Dr Thomas Le |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 150 E Yorba Linda Blvd, Placentia, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144596511 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 55979 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Le, PHARMD 150 E. Yorba Linda Blvd., Placentia, CA 92870 Ph: (714) 528-3112 | Dr Thomas Le, PHARMD 150 E Yorba Linda Blvd, Placentia, CA 92870-3327 Ph: (714) 528-3112 |
News Archive
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
During the first wave of the corona pandemic, 36 per cent fewer men were diagnosed with prostate cancer in Sweden than in previous years.
Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.
The following is a statement of Matthew L. Myers President, Campaign for Tobacco-Free Kids: A new report published today by the U.S. Centers for Disease Control and Prevention provides powerful and concrete evidence that the nation's battle against tobacco use has not only driven down smoking rates, but is also saving lives by reducing lung cancer, the number one cancer killer in the United States.
A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. This product was approved with a Medication Guide.
› Verified 5 days ago
Dr. Parth Prashant Parikh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Del Rey Dr, Placentia, CA 92870 Phone: 714-470-2309 | |
Jennifer Mae Ilagan Flores, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1875 N Kraemer Blvd, Placentia, CA 92870 Phone: 714-572-5656 | |
Dema Askar, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 Davis Way, Placentia, CA 92870 Phone: 714-343-3350 | |
Mr. Michael Yuwei Wong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 419 Downey Ln, Placentia, CA 92870 Phone: 714-996-5665 | |
Brandy Ta, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1875 N Kraemer Blvd, Placentia, CA 92870 Phone: 714-572-5656 Fax: 714-572-5662 | |
Kristina Kawase, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 E Yorba Linda Blvd, Placentia, CA 92870 Phone: 714-579-7451 |